Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
Abstract Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are human neuromuscular disorders associated with mutations of simple repetitive sequences in affected genes. The abnormal expansion of CTG repeats in the 3′-UTR of the DMPK gene elicits DM1, whereas elongated CCTG repeats in intron 1 of ZNF9...
Guardado en:
Autores principales: | Marzena Wojciechowska, Krzysztof Sobczak, Piotr Kozlowski, Saam Sedehizadeh, Agnieszka Wojtkowiak-Szlachcic, Karol Czubak, Robert Markus, Anna Lusakowska, Anna Kaminska, J. David Brook |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f98b45be94545c6a92269f3ba50f1e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epigenetics of Myotonic Dystrophies: A Minireview
por: Virginia Veronica Visconti, et al.
Publicado: (2021) -
Cardiac Pathology in Myotonic Dystrophy Type 1
por: Mani S. Mahadevan, et al.
Publicado: (2021) -
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
por: Jie Liu, et al.
Publicado: (2021) -
Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies
por: Banach M, et al.
Publicado: (2017) -
Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy
por: Thiéry De Serres-Bérard, et al.
Publicado: (2021)